seekingalpha.com
Barclays PLC (BCS) Presents at European Financials Conference 2026 Transcript
Barclays PLC (BCS) Presents at European Financials Conference 2026 Transcript
Barclays PLCBCSNYSE
Loading
Latest News
newsfilecorp.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS
New York, New York--(Newsfile Corp. - March 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Barclays securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
zacks.com
EU Banks Get Breathing Room as Capital Rule Decisions Face Delays
EU delays FRTB capital rules again, giving DB, BCS and BNPQY near-term relief while uncertainty lingers over Basel III rollout.
globenewswire.com
Barclays Investor News: If You Have Suffered Losses in Barclays PLC (NYSE: BCS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.
prnewswire.com
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS
NEW YORK, March 16, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public. So What: If you purchased Barclays securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
newsfilecorp.com
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS
New York, New York--(Newsfile Corp. - March 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Barclays securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
newsfilecorp.com
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS
New York, New York--(Newsfile Corp. - March 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Barclays securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
reuters.com
Barclays raises 2026 Brent forecast to $85 a barrel on Strait of Hormuz disruption
Barclays on Friday raised its 2026 Brent crude forecast to $85 per barrel, citing ongoing supply disruptions linked to the Iran war that have sharply reduced oil flows through the Strait of Hormuz.
newsfilecorp.com
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS
New York, New York--(Newsfile Corp. - March 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Barclays securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
globenewswire.com
Barclays Investor News: If You Have Suffered Losses in Barclays PLC (NYSE: BCS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.
marketbeat.com
Just Buy It? Barclays Thinks Nike Is Ready to Run
For months, investors have watched Nike, Inc. NYSE: NKE, a titan of the consumer discretionary world, struggle to find its footing, testing the patience of even its most loyal shareholders. The stock's persistent underperformance has been a key storyline.
businesswire.com
U.S. Physical Therapy Presented at the Barclays 28th Annual Global Healthcare Conference
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chairman and Chief Executive Officer, presented at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 783 outpatient physi.
investopedia.com
Nike's Stock Gets an Upgrade. Barclays Says It's Likely Reached a 'Fundamental Bottom.
Nike's stock could soon be due for a rebound, according to analysts at Barclays.
seekingalpha.com
Zealand Pharma A/S (ZLDPF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
marketwatch.com
Tariff refunds are expected to come in the second quarter: Barclays
The Trump administration's new replacement tariffs could result in a lower effective rate of 9.1%, according to a strategist at J.P. Morgan Asset Management.
globenewswire.com
BCS Investors Have Opportunity to Join Barclays PLC Fraud Investigation with the Schall Law Firm
LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Barclays PLC (“Barclays” or “the Company”) (NYSE: BCS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
247wallst.com
AI Disruption Fears Overdone, Says Barclays — Upgrades Arthur J. Gallagher and Willis Towers Watson
Barclays is pushing back against the narrative that artificial intelligence poses an existential threat to insurance brokers, upgrading two of the sector's largest names while trimming its price target on a third.
prnewswire.com
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS
NEW YORK, March 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public. So What: If you purchased Barclays securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
seekingalpha.com
Elevance Health, Inc. (ELV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Elevance Health, Inc. (ELV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
proactiveinvestors.co.uk
Barclays named a top global investment bank pick as JP Morgan says trading boom has further to run
Analyst sees European banks closing valuation gap with Wall Street giants Goldman and Morgan Stanley Barclays PLC (LSE:BARC) has been named a top pick among global investment banks by JP Morgan. It has upgraded its trading revenue forecasts across the sector after concluding that market volatility sparked by Middle East tensions will drive one of the strongest quarters for trading revenues on record.